Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 105,256 | 31,753 | 11,691 | N/A |
| TOTAL | $107,511 | $32,178 | $11,926 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 33 | 29 | 16 | N/A |
| Other Non-Current Assets | 200 | 80 | 20 | 0 |
| TOTAL | $233 | $109 | $36 | $N/A |
| Total Assets | $107,744 | $32,287 | $11,962 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 765 | 5 | 764 | 0 |
| Accrued Expenses | 3,478 | 2,204 | 1,254 | N/A |
| TOTAL | $4,243 | $2,209 | $2,018 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 85,345 | 49,845 | 0 |
| TOTAL | $N/A | $85,345 | $49,845 | $N/A |
| Total Liabilities | $4,243 | $87,554 | $51,863 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 138 | N/A | N/A | N/A |
| Common Shares | 22 | N/A | N/A | N/A |
| Retained earnings | -86,351 | -63,055 | -47,330 | N/A |
| TOTAL | $103,501 | $-55,267 | $-39,901 | $N/A |
| Total Liabilities And Equity | $107,744 | $32,287 | $11,962 | $0 |